These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
754 related articles for article (PubMed ID: 34370958)
1. Posterior reversible encephalopathy syndrome during convalescence from COVID-19. Michel-Chávez A; García-Grimshaw M; Chávez-Martínez OA; Cantú-Brito C; Romero-Sánchez GT; Flores-Silva FD; Merayo-Chalico FJ; Martínez-Carrillo FM; Barrera-Vargas A; Valdés-Ferrer SI Int J Neurosci; 2023 Jun; 133(6):672-675. PubMed ID: 34370958 [No Abstract] [Full Text] [Related]
2. Posterior reversible encephalopathy syndrome (PRES) associated with SARS-CoV-2 infection in a patient under maintenance haemodialysis: a case report. Shimamoto Y; Sasaki H; Kasuno K; Watanabe Y; Sakashita S; Nishikawa S; Nishimori K; Morita S; Nishikawa Y; Kobayashi M; Fukushima S; Enomoto S; Takahashi N; Hamano T; Sakamaki I; Iwasaki H; Iwano M BMC Nephrol; 2023 Sep; 24(1):286. PubMed ID: 37773103 [TBL] [Abstract][Full Text] [Related]
3. Posterior reversible encephalopathy syndrome - A pathology that should not be overlooked in the era of COVID-19. Ioan P; Ribigan AC; Rusu O; Bratu IF; Badea RS; Antochi F Am J Emerg Med; 2022 Jun; 56():393.e5-393.e8. PubMed ID: 35346531 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 may play a direct role in the pathogenesis of posterior reversible encephalopathy syndrome (PRES) associated with COVID-19: A CARE-compliant case report and literature review. Wang L; Wang Z; Huang R; Li W; Zheng D Medicine (Baltimore); 2024 Feb; 103(5):e37192. PubMed ID: 38306528 [TBL] [Abstract][Full Text] [Related]
5. Posterior reversible encephalopathy syndrome (PRES) associated with COVID-19. Lallana S; Chen A; Requena M; Rubiera M; Sanchez A; Siegler JE; Muchada M J Clin Neurosci; 2021 Jun; 88():108-112. PubMed ID: 33992168 [TBL] [Abstract][Full Text] [Related]
6. Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient. Princiotta Cariddi L; Tabaee Damavandi P; Carimati F; Banfi P; Clemenzi A; Marelli M; Giorgianni A; Vinacci G; Mauri M; Versino M J Neurol; 2020 Nov; 267(11):3157-3160. PubMed ID: 32583053 [TBL] [Abstract][Full Text] [Related]
7. Posterior Reversible Leukoencephalopathy Syndrome in a Patient after Acute COVID-19 Infection. Kobaidze K; Shin YM; Japaridze M; Karakis I; Wu X Case Rep Neurol Med; 2021; 2021():5564802. PubMed ID: 33996162 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 associated posterior reversible encephalopathy syndrome (PRES) - a review of 82 cases. Finsterer J Med J Malaysia; 2023 May; 78(3):421-426. PubMed ID: 37271853 [TBL] [Abstract][Full Text] [Related]
11. Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature. Motolese F; Ferrante M; Rossi M; Magliozzi A; Sbarra M; Ursini F; Marano M; Capone F; Travaglino F; Antonelli Incalzi R; Di Lazzaro V; Pilato F J Neurol; 2021 Dec; 268(12):4407-4414. PubMed ID: 34291313 [TBL] [Abstract][Full Text] [Related]
12. Posterior reversible encephalopathy syndrome in a child with severe multisystem inflammatory syndrome due to COVID-19. Dominguez-Rojas JA; AtamariAnahui N; Caqui-Vilca P; TelloPezo M; Muñoz-Huerta P Rev Bras Ter Intensiva; 2022; 34(2):295-299. PubMed ID: 35946661 [TBL] [Abstract][Full Text] [Related]
17. Myoclonus status revealing COVID 19 infection. Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232 [TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]